DICYCLOMINE Drug Patent Profile
✉ Email this page to a colleague
When do Dicyclomine patents expire, and when can generic versions of Dicyclomine launch?
Dicyclomine is a drug marketed by Annora Pharma, Aurobindo Pharma Usa, Corepharma, Lannett, Pioneer Pharms, Prinston Inc, Rising, Rubicon Research, Sun Pharm Industries, Twi Pharms, Watson Labs, West Ward, Am Regent, Dr Reddys, Fosun Pharma, Fresenius Kabi Usa, Hikma, Nexus, Praxgen Pharms, Renew Pharms, Slate Run Pharma, Somerset Theraps Llc, Alpharma Us Pharms, Novitium Pharma, Ph Health, Bionpharma, and Hikma Pharms. and is included in forty-three NDAs.
The generic ingredient in DICYCLOMINE is dicyclomine hydrochloride. There is one drug master file entry for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dicyclomine
A generic version of DICYCLOMINE was approved as dicyclomine hydrochloride by WATSON LABS on June 19th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DICYCLOMINE?
- What are the global sales for DICYCLOMINE?
- What is Average Wholesale Price for DICYCLOMINE?
Summary for DICYCLOMINE
| US Patents: | 0 |
| Applicants: | 27 |
| NDAs: | 43 |
| Drug Prices: | Drug price information for DICYCLOMINE |
| Drug Sales Revenues: | Drug sales revenues for DICYCLOMINE |
| DailyMed Link: | DICYCLOMINE at DailyMed |
US Patents and Regulatory Information for DICYCLOMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Twi Pharms | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | TABLET;ORAL | 216782-001 | Jun 1, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Corepharma | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | TABLET;ORAL | 216760-001 | Nov 28, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ph Health | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | SYRUP;ORAL | 040169-001 | Mar 24, 2005 | AA | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
